IBDEI083 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10606,1,3,0)
 ;;=3^Ophthalmoplegia,Total
 ;;^UTILITY(U,$J,358.3,10606,1,4,0)
 ;;=4^378.56
 ;;^UTILITY(U,$J,358.3,10606,2)
 ;;=^269269
 ;;^UTILITY(U,$J,358.3,10607,0)
 ;;=378.60^^64^627^24
 ;;^UTILITY(U,$J,358.3,10607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10607,1,3,0)
 ;;=3^Strabismus Mech,Unspec
 ;;^UTILITY(U,$J,358.3,10607,1,4,0)
 ;;=4^378.60
 ;;^UTILITY(U,$J,358.3,10607,2)
 ;;=^265445
 ;;^UTILITY(U,$J,358.3,10608,0)
 ;;=378.62^^64^627^25
 ;;^UTILITY(U,$J,358.3,10608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10608,1,3,0)
 ;;=3^Strabismus,Mech MF D/O
 ;;^UTILITY(U,$J,358.3,10608,1,4,0)
 ;;=4^378.62
 ;;^UTILITY(U,$J,358.3,10608,2)
 ;;=^269272
 ;;^UTILITY(U,$J,358.3,10609,0)
 ;;=378.15^^64^627^10
 ;;^UTILITY(U,$J,358.3,10609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10609,1,3,0)
 ;;=3^Exotropia,Alternating
 ;;^UTILITY(U,$J,358.3,10609,1,4,0)
 ;;=4^378.15
 ;;^UTILITY(U,$J,358.3,10609,2)
 ;;=^265415
 ;;^UTILITY(U,$J,358.3,10610,0)
 ;;=378.11^^64^627^11
 ;;^UTILITY(U,$J,358.3,10610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10610,1,3,0)
 ;;=3^Exotropia,Monocular
 ;;^UTILITY(U,$J,358.3,10610,1,4,0)
 ;;=4^378.11
 ;;^UTILITY(U,$J,358.3,10610,2)
 ;;=^265413
 ;;^UTILITY(U,$J,358.3,10611,0)
 ;;=378.51^^64^627^17
 ;;^UTILITY(U,$J,358.3,10611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10611,1,3,0)
 ;;=3^Nerve Palsy,Partial Third
 ;;^UTILITY(U,$J,358.3,10611,1,4,0)
 ;;=4^378.51
 ;;^UTILITY(U,$J,358.3,10611,2)
 ;;=^118774
 ;;^UTILITY(U,$J,358.3,10612,0)
 ;;=378.54^^64^627^18
 ;;^UTILITY(U,$J,358.3,10612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10612,1,3,0)
 ;;=3^Nerve Palsy,Sixth
 ;;^UTILITY(U,$J,358.3,10612,1,4,0)
 ;;=4^378.54
 ;;^UTILITY(U,$J,358.3,10612,2)
 ;;=^265334
 ;;^UTILITY(U,$J,358.3,10613,0)
 ;;=378.53^^64^627^16
 ;;^UTILITY(U,$J,358.3,10613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10613,1,3,0)
 ;;=3^Nerve Palsy,Fourth
 ;;^UTILITY(U,$J,358.3,10613,1,4,0)
 ;;=4^378.53
 ;;^UTILITY(U,$J,358.3,10613,2)
 ;;=^265326
 ;;^UTILITY(U,$J,358.3,10614,0)
 ;;=360.01^^64^628^49
 ;;^UTILITY(U,$J,358.3,10614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10614,1,3,0)
 ;;=3^Endophalmitis
 ;;^UTILITY(U,$J,358.3,10614,1,4,0)
 ;;=4^360.01
 ;;^UTILITY(U,$J,358.3,10614,2)
 ;;=Endophalmitis^268545
 ;;^UTILITY(U,$J,358.3,10615,0)
 ;;=V08.^^64^628^52
 ;;^UTILITY(U,$J,358.3,10615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10615,1,3,0)
 ;;=3^HIV Status
 ;;^UTILITY(U,$J,358.3,10615,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,10615,2)
 ;;=HIV Status^303392
 ;;^UTILITY(U,$J,358.3,10616,0)
 ;;=130.2^^64^628^86
 ;;^UTILITY(U,$J,358.3,10616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10616,1,3,0)
 ;;=3^Toxoplasmosis Retinitis
 ;;^UTILITY(U,$J,358.3,10616,1,4,0)
 ;;=4^130.2
 ;;^UTILITY(U,$J,358.3,10616,2)
 ;;=Toxoplasmosis Retinitis^266947
 ;;^UTILITY(U,$J,358.3,10617,0)
 ;;=128.0^^64^628^85
 ;;^UTILITY(U,$J,358.3,10617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10617,1,3,0)
 ;;=3^Toxocariasis
 ;;^UTILITY(U,$J,358.3,10617,1,4,0)
 ;;=4^128.0
 ;;^UTILITY(U,$J,358.3,10617,2)
 ;;=Toxocariasis^120683
 ;;^UTILITY(U,$J,358.3,10618,0)
 ;;=054.42^^64^628^47
 ;;^UTILITY(U,$J,358.3,10618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10618,1,3,0)
 ;;=3^Dendritic Keratitis
 ;;^UTILITY(U,$J,358.3,10618,1,4,0)
 ;;=4^054.42
 ;;^UTILITY(U,$J,358.3,10618,2)
 ;;=Dendritic Keratitis^66763
 ;;^UTILITY(U,$J,358.3,10619,0)
 ;;=370.01^^64^628^64
 ;;^UTILITY(U,$J,358.3,10619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10619,1,3,0)
 ;;=3^Marginal Corneal Ulcer
 ;;^UTILITY(U,$J,358.3,10619,1,4,0)
 ;;=4^370.01
 ;;^UTILITY(U,$J,358.3,10619,2)
 ;;=Marginal Corneal Ulcer^268908
 ;;^UTILITY(U,$J,358.3,10620,0)
 ;;=375.30^^64^628^46
 ;;^UTILITY(U,$J,358.3,10620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10620,1,3,0)
 ;;=3^Dacrocystitis
 ;;^UTILITY(U,$J,358.3,10620,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,10620,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,10621,0)
 ;;=376.01^^64^628^68
 ;;^UTILITY(U,$J,358.3,10621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10621,1,3,0)
 ;;=3^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,10621,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,10621,2)
 ;;=Orbital Cellulitis^259068
 ;;^UTILITY(U,$J,358.3,10622,0)
 ;;=682.0^^64^628^6
 ;;^UTILITY(U,$J,358.3,10622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10622,1,3,0)
 ;;=3^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,10622,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,10622,2)
 ;;=Cellulitis of Face^271888
 ;;^UTILITY(U,$J,358.3,10623,0)
 ;;=473.9^^64^628^83
 ;;^UTILITY(U,$J,358.3,10623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10623,1,3,0)
 ;;=3^Sinusitis,Unspec
 ;;^UTILITY(U,$J,358.3,10623,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,10623,2)
 ;;=Sinusitis^123985
 ;;^UTILITY(U,$J,358.3,10624,0)
 ;;=017.30^^64^628^89
 ;;^UTILITY(U,$J,358.3,10624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10624,1,3,0)
 ;;=3^Tuberculosis,Eye
 ;;^UTILITY(U,$J,358.3,10624,1,4,0)
 ;;=4^017.30
 ;;^UTILITY(U,$J,358.3,10624,2)
 ;;=^122722
 ;;^UTILITY(U,$J,358.3,10625,0)
 ;;=076.9^^64^628^87
 ;;^UTILITY(U,$J,358.3,10625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10625,1,3,0)
 ;;=3^Trachoma,Unspec
 ;;^UTILITY(U,$J,358.3,10625,1,4,0)
 ;;=4^076.9
 ;;^UTILITY(U,$J,358.3,10625,2)
 ;;=^120805
 ;;^UTILITY(U,$J,358.3,10626,0)
 ;;=077.0^^64^628^30
 ;;^UTILITY(U,$J,358.3,10626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10626,1,3,0)
 ;;=3^Conjunctivitis,Inclusion
 ;;^UTILITY(U,$J,358.3,10626,1,4,0)
 ;;=4^077.0
 ;;^UTILITY(U,$J,358.3,10626,2)
 ;;=^27600
 ;;^UTILITY(U,$J,358.3,10627,0)
 ;;=077.1^^64^628^60
 ;;^UTILITY(U,$J,358.3,10627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10627,1,3,0)
 ;;=3^Keratoconjunctivitis,Epidemic EKC
 ;;^UTILITY(U,$J,358.3,10627,1,4,0)
 ;;=4^077.1
 ;;^UTILITY(U,$J,358.3,10627,2)
 ;;=^41251
 ;;^UTILITY(U,$J,358.3,10628,0)
 ;;=077.8^^64^628^37
 ;;^UTILITY(U,$J,358.3,10628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10628,1,3,0)
 ;;=3^Conjunctivitis,Viral,Oth
 ;;^UTILITY(U,$J,358.3,10628,1,4,0)
 ;;=4^077.8
 ;;^UTILITY(U,$J,358.3,10628,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,10629,0)
 ;;=077.99^^64^628^36
 ;;^UTILITY(U,$J,358.3,10629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10629,1,3,0)
 ;;=3^Conjunctivitis,Viral Unspec
 ;;^UTILITY(U,$J,358.3,10629,1,4,0)
 ;;=4^077.99
 ;;^UTILITY(U,$J,358.3,10629,2)
 ;;=^295786
 ;;^UTILITY(U,$J,358.3,10630,0)
 ;;=078.5^^64^628^45
 ;;^UTILITY(U,$J,358.3,10630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10630,1,3,0)
 ;;=3^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,10630,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,10630,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,10631,0)
 ;;=090.3^^64^628^58
 ;;^UTILITY(U,$J,358.3,10631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10631,1,3,0)
 ;;=3^Keratitis,Interstitial,Syphilitic
 ;;^UTILITY(U,$J,358.3,10631,1,4,0)
 ;;=4^090.3
 ;;^UTILITY(U,$J,358.3,10631,2)
 ;;=^266697
 ;;^UTILITY(U,$J,358.3,10632,0)
 ;;=091.50^^64^628^92
 ;;^UTILITY(U,$J,358.3,10632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10632,1,3,0)
 ;;=3^Uveitis Syphilitica,Unspec
 ;;^UTILITY(U,$J,358.3,10632,1,4,0)
 ;;=4^091.50
 ;;^UTILITY(U,$J,358.3,10632,2)
 ;;=^266715
 ;;^UTILITY(U,$J,358.3,10633,0)
 ;;=094.83^^64^628^82
 ;;^UTILITY(U,$J,358.3,10633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10633,1,3,0)
 ;;=3^Retinochoroiditis,Dissem,Syphilitic
 ;;^UTILITY(U,$J,358.3,10633,1,4,0)
 ;;=4^094.83
 ;;^UTILITY(U,$J,358.3,10633,2)
 ;;=^266752
 ;;^UTILITY(U,$J,358.3,10634,0)
 ;;=099.3^^64^628^81
 ;;^UTILITY(U,$J,358.3,10634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10634,1,3,0)
 ;;=3^Reiter's Disease
 ;;^UTILITY(U,$J,358.3,10634,1,4,0)
 ;;=4^099.3
 ;;^UTILITY(U,$J,358.3,10634,2)
 ;;=^104534
 ;;^UTILITY(U,$J,358.3,10635,0)
 ;;=112.89^^64^628^5
 ;;^UTILITY(U,$J,358.3,10635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10635,1,3,0)
 ;;=3^Candida,Oth
 ;;^UTILITY(U,$J,358.3,10635,1,4,0)
 ;;=4^112.89
 ;;^UTILITY(U,$J,358.3,10635,2)
 ;;=^87368
 ;;^UTILITY(U,$J,358.3,10636,0)
 ;;=136.1^^64^628^1
 ;;^UTILITY(U,$J,358.3,10636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10636,1,3,0)
 ;;=3^Behcet's Disease
 ;;^UTILITY(U,$J,358.3,10636,1,4,0)
 ;;=4^136.1
 ;;^UTILITY(U,$J,358.3,10636,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,10637,0)
 ;;=190.3^^64^628^10
 ;;^UTILITY(U,$J,358.3,10637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10637,1,3,0)
 ;;=3^Conjunctiva Malig Neopl
 ;;^UTILITY(U,$J,358.3,10637,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,10637,2)
 ;;=^267274
 ;;^UTILITY(U,$J,358.3,10638,0)
 ;;=198.89^^64^628^90
 ;;^UTILITY(U,$J,358.3,10638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10638,1,3,0)
 ;;=3^Uveal Metastasis
 ;;^UTILITY(U,$J,358.3,10638,1,4,0)
 ;;=4^198.89
 ;;^UTILITY(U,$J,358.3,10638,2)
 ;;=^267330
 ;;^UTILITY(U,$J,358.3,10639,0)
 ;;=202.80^^64^628^63
 ;;^UTILITY(U,$J,358.3,10639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10639,1,3,0)
 ;;=3^Lymphoma,Extranod/Solid Org,Unspec Site
 ;;^UTILITY(U,$J,358.3,10639,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,10639,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,10640,0)
 ;;=224.3^^64^628^11
 ;;^UTILITY(U,$J,358.3,10640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10640,1,3,0)
 ;;=3^Conjunctiva,Benign Neopl
 ;;^UTILITY(U,$J,358.3,10640,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,10640,2)
 ;;=^267673
 ;;^UTILITY(U,$J,358.3,10641,0)
 ;;=238.8^^64^628^67
 ;;^UTILITY(U,$J,358.3,10641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10641,1,3,0)
 ;;=3^Neopl,Uncert Behavior,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,10641,1,4,0)
 ;;=4^238.8
 ;;^UTILITY(U,$J,358.3,10641,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,10642,0)
 ;;=360.11^^64^628^91
 ;;^UTILITY(U,$J,358.3,10642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10642,1,3,0)
 ;;=3^Uveitis Sympathetic
 ;;^UTILITY(U,$J,358.3,10642,1,4,0)
 ;;=4^360.11
 ;;^UTILITY(U,$J,358.3,10642,2)
 ;;=^85809
 ;;^UTILITY(U,$J,358.3,10643,0)
 ;;=360.12^^64^628^73
